Demographic properties and initial assessments of the patients
| Variable | CESI group (n = 34) | GIB group (n = 34) | |
|---|---|---|---|
| Age (yr) | 46.2 ± 11.9 | 46.0 ± 13.7 | 0.953 |
| Female | 26 (76.5) | 23 (67.6) | 0.412 |
| BMI (kg/m2) | 26.7 ± 4.5 | 27.7 ± 4.6 | 0.364 |
| Symptom duration (mo) | 12.4 ± 7.8 | 11.9 ± 6.3 | 0.981 |
| Positive history of trauma | 20 (58.8) | 19 (55.9) | 0.800 |
| Initial NRS | 8.5 ± 1.0 | 7.9 ± 1.2 | 0.200 |
| Initial SF-12 | 40.4 ± 13.3 | 39.3 ± 13.6 | 0.724 |
| Presence of neuropathic pain according to LANSS | 18 (52.9) | 18 (52.9) | > 0.999 |
| Drugs | |||
| NSAIDs | 13 (38.2) | 11 (32.4) | 0.724 |
| Paracetamol | 4 (11.8) | 4 (11.8) | > 0.999 |
| Tramadol | 3 (8.8) | 2 (5.9) | 0.663 |
| Gabapentinoids | 14 (41.2) | 14 (41.2) | > 0.999 |
| Duloxetine | 6 (17.6) | 5 (14.7) | 0.762 |
Values are presented as mean ± standard deviation or number (%).
CESI: caudal epidural steroid injection, GIB: ganglion impar block, BMI: body mass index, NRS: numeric rating scale, SF-12: Short Form-12 Health Survey, LANSS: Leeds Assessment of Neuropathic Symptoms and Signs Scale, NSAID: nonsteroidal anti-inflammatory drug.